Chapter III ANTIVIRAL AND ANTIFUNGAL DRUGS

Similar documents
Antifungal drugs Dr. Raz Muhammed

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Antifungals, antivirals, antiprotozoals, and anthelmintics

B. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.

Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP

Antiviral Chemotherapy

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

- They come in all sizes. -- General Structure is similar.

Antiviral Agents DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU. 06 August

Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

ANTIMYCOTIC DRUGS Modes of Action

Antiviral Chemotherapy

Steps in viral replication (I)

Course content. Chemotherapeutic agents

Antiviral Drugs Lecture 5

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)

ANTIFUNGAL AGENTS. Alison Clode, DVM, DACVO. Port City Veterinary Referral Hospital Portsmouth, New Hampshire

Antiviral Agents I. Tutorial 6

Chapter 49. Antiviral Agents

(Notes on Anti-TB agents are included in the TB syllabus)

Medicinal Chemistry 410 Exam #1 February 20, 2009 Name: Med. Chem. #

Understanding Viruses CHAPTER 38. Antiviral Agents. Understanding Viruses (cont'd) Viral Infections (cont'd) Viral Infections.

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

gram neg.(semisynthetic) Bacteria Drugs that inhibit cell wall synthesis Drug Action Organisms Comments Spectrum of Action Mycobacterium

I is a cascading prodrug. II is used to treat hepatitis B infection III ultimately inhibits viral reverse transcriptase.

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Pharmaceutical Chemistry II. Antifungal Agents. = Antimycotics. Tutorial 1

Structure of viruses

Antiviral Agents, chapter 43

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6

Year 2002 Paper two: Questions supplied by Jo 1

Med Chem 401: Mycology ( Mycology

HIV - Life cycle. HIV Life Cyle

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

*viruses have no cell wall and made up of nucleic acid components.

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV) modified by Diala Abul Haija

MID 40. Diagnosis of Viral Infections. Antiviral Therapy. Herpes Zoster. Challenges to the Development of Effective Antiviral Agents

BUGS and DRUGS Part 2 March 13, 2013 Marieke Kruidering- Hall

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan

Viral genetics VIRAL GENETICS

Immunodeficiencies HIV/AIDS

Diagnosis of Viral Infections. Antiviral Agents. Herpes Zoster. Challenges to the Development of Effective Antiviral Agents

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

Antiviral Agents. Scott M. Hammer, M.D. Challenges to the Development of Effective Antiviral Agents

number Done by Corrected by Doctor Ashraf

Ali Alabbadi. Sarah Jaar ... Nader

Intrinsic cellular defenses against virus infection

Antivirals. Lecture 20 Biology 3310/4310 Virology Spring 2017

PHARMACEUTICAL CHEMISTRY II (PHCM672) Lecture 1, Antifungal Drugs (Antimycotics) Dr. Mohammad Abdel-Halim

The sensitivity of fungal microorganisms to fluconazole is as follows:

CHAPTER ONE: EXECUTIVE SUMMARY

Epidemiology and ecology of fungal diseases

The head of a pin can hold five hundred million rhinoviruses (cause of the

Biochemical Targets for Antifungal Chemotherapy

3. on T helper {cells / lymphocytes} ; 3. ACCEPT macrophages / dendritic cells / CD4 cells

Management of fungal infection

About the Editor Gerri S. Hall, Ph.D.

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

Viral Genetics. BIT 220 Chapter 16

& VIRAL EYE PATHOGENS

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Continuing Education for Pharmacy Technicians

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

What is HIV? Shoba s story. What is HIV?

Improving Clinical Outcomes in Fungal Infection Control and Management

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory ZODERM E CREAM. Oxiconazole Nitrate Cream

Viral reproductive cycle

HIV and AIDS. Shan Nanji

C. albicans C. tropicalis C. parapsilosis C. kefyr C. glabrata C. krusei C. guillermondii C. lusitaniae THERAPY USING ANTIFUNGALS AND ANTIVIRALS

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Current Options in Antifungal Pharmacotherapy

number Done by Corrected by Doctor د.حامد الزعبي

HIV epidemiology since HIV in the United States. HIV Transmission

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

Concomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.

Biochemical Targets for Antifungal Chemotherapy

SUSCEPTIBILITY PROFILE OF EMERGING FUNGAL PATHOGENS

Management of NRTI Resistance

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

ITRANOX. Composition Each capsule contains :

Antifungal Drugs 35 I. OVERVIEW II. DRUGS FOR SUBCUTANEOUS AND SYSTEMIC MYCOTIC INFECTIONS

Drugs dermatological conditions II

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission

8/13/2009. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Shapes. Domain Bacteria Characteristics

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

Treatment Op+ons for Chronic Hepa++s B. Judith Feinberg, MD Project ECHO Jan. 19, 2017

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Voriconazole. Voriconazole VRCZ ITCZ

Clinical Case Scenario. HIVeEducation Workshop, Sint Maarten 2009

MedChem 401~ Retroviridae. Retroviridae

Antifungal resistance mechanisms in pathogenic fungi

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms

Transcription:

Chapter III ANTIVIRAL AND ANTIFUNGAL DRUGS AN OUNCE OF PREVENTION WORTH POUND OF CURE Year III Pharm.D Dr. V. Chitra

ANTIVIRAL DRUGS Viruses are small(20-30 nm) infective agents that are incapable of reproduction outside their host cells

DIFFERENT HOST DEFENCES: Skin T-lymphocytes NK cells Gene silencing VIRAL PLOY: Subversion of immune response Interference with surface protein markers Interference with apoptotic pathway Adopting baby turkey ploy

NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Mechanism of action: Phosphorylation to 5 -triphosphate residues Competes with host triphosphate for proviral DNA synthesis Incorporation into growing viral DNA and chain termination

DRUG ANALOGUE HALF-LIFE R.O.A ADR ZIDOVUDINE( AZT) THYMIDINE 1-3 HR ORAL ANEAMIA,MYOPA THY DIDANOSINE( ddi) ADENOSINE 1-1.5 HR ORAL PERIPHERAL NEUROPATHY STAVUDINE(d 4T) THYMIDINE 1.5 HR ORAL LIPODYSTROPHY LAMIVUDINE( 3TC) CYTOSINE 6-8 HR ORAL ANOREXIA ABACAVIR(AB C) GUANOSINE 1-1.5,12 HR ORAL HYPERSENSITIVIT Y AND FLU LIKE SYMPTOMS

NON-NUCLESIDE REVERSE TRANSCRIPTASE UNHIBITORS NEVIRAPINE Orally well absorbed Bioavailability-90% T1/2-30 hours Prevent mother to baby transmission Hepatotoxic EFAVIRENZ: Bioavailability-50% T1/2-48 hours 99% albumin bound Insomnia,dizziness

PROTEASE INHIBITORS Saquinavir,nelfinavir,indinavir,ritonavir,amprenavir Given orally Increase CD4 count in AIDS patients Tablet load is high Lipodystrophy,numbness,rhabdomyolysis are adverse effects

DNA POLYMERASE INHIBITORS Mechanism of action: Converted to monophosphate by thymidine kinase of virus Host cell convert monophosphate to triphosphate Inhibits DNA polymerase and terminate nucleotide chain

DRUG ANALOGU E DRUG OF CHOICE FOR R.O.A HALF LIFE ADR ACICLOVIR GUANIDINE HERPES,VA RICELLA GANCICLO VIR GUANIDINE CYTOMEGA LY RIBAVIRIN GUANIDINE SYNCYTIAL VIRUS I.V,TOPICAL 2-3 HR TREMORS,M ALAISE,REN AL DYSFUNCTI ON I.V 2-4 HR CARCINOG ENECITY,BO NE MARROW DEPRESSIO N I.V 2-3 HR INSOMNIA, MYALGIA FOSCARNET NON NUCLEOSID E CYTOMEGA LY ORAL 4-8 HR ANEAMIA,C ONVULSION

INHIBITORS OF VIRAL FUSION: ENFURVIRTIDE: Given subcutaneously Flu like symptoms NEURAMINIDASE AND VIRAL COAT ASSEMBLY INHIBITORS: ZANAMIVIR AND OSELTAMIVIR- Inhalation and oral preparation G.I upset AMANTIDINE AND RIMANTIDINE- Block M2 ion channel Effective only against influenza A virus Dizziness,insomnia,slurred speech

BIOLOGICS AND IMMUNOMODULATORS Immunoglobulin: Pooled antibodies against virus envelope are used Hyperimmune globulin against hepatitis B,rabies,varicella are used Palivisumab: Monoclonal antibody directed against glycoprotein on surface of syncytial virus Inosine pranobex: Interfere with viral nucleic acid synthesis and has immunopotentiating action on host

INTERFERONS: Bind to specific ganglioside receptors on host cell Induce enzymes that inhibit viral mrna translation Broad spectrum Half life of 2-4 hours Donot cross blood brain barrier Interferon-α-2a treatment of hepatitis B and kaposi sarcoma Interferon-α-2b treatment of hepatitis C Myalgia,bone marrow depression,alopecia

ANTIFUNGAL AGENTS Fungi are eukaryotic,complex and more evolved organisms Most fungal infections are opportunistic in nature ORGANISM PRINCIPAL DISEASE Cryptococcus neoformans Candida albicans Trichophyton spp. Microsporum spp. Epidermophyton Aspergillus fumigatus Histoplasma capsulatum Coccidioides immitis Meningitis Systemic candidiasis Skin and nail infections Skin and nail infections Skin and nail infections Pulmonary aspergillosis Histoplasmosis coccidiomycosis

POLYENES: ANTIBIOTICS Amphoterecin B:Obtained from streptomyces nodosus Has high affinity to ergosterol Several polyene molecules orient to form a micropore Hydrophilic side towards interior through which ions move out Broad spectrum antibiotic Fungicidal at high and static at low concentrations Given orally and I.V as a suspension Nephrotoxicity,hypersensitivity,thrombocytopenia Used topically for oral,vaginal and cutaneous candidiasis,leishmaniasis

HETEROCYCLIC BENZOFURAN: Antibiotic extracted from pencillium griesofulvum Not active agaist candida and deep mycosis infections Fungistatic by interfering with microtubules and arresting cell division Given orally along with fatty meal Plasma half life is 24 hours Photosensitivity and allergy are common ECHINOCANDINS Found naturally in A.nidulans Inhibit synthesis of 1,3-β glucan,glucose polymer for cell wall synthesis

IMIDAZOLES AND TRIAZOLES Group of synthetic fungistatic agents with broad spectrum of activity Imidazoles clotrimazole,econazole,ketoconazole,miconazole,tioconazole Triazole itraconazole,voriconazole,fluconazole Act by inhibiting lanosine 14α demethylase responsible for converting lanosterol to ergosterol Alters fluidity of membrane and inhibit replication Inhibit transformation of candidial yeast cells to hyphae,the invasive form

DRUG R.O.A HALF LIFE USES ADR KETOCONAZO LE ORAL 1.5-6 HOURS DERMATOPHY TOSIS,KALA AZAR GYNACOMAS TIA,ALOPECIA FLUCONAZOL E ORAL,I.V 25-60 HOURS CANDIDIASIS, COCCIDIOID AL ABDOMINAL PAIN ITRACONAZO LE ORAL 30-64 HOURS ASPERGILLOSI S,MYCOSIS PRURITIS,IMP OTENCE,L.V DYSFUNCTION

FLUCYTOSINE: TERBINAFINE: Orally active narrow spectrum drug Converted to antimetabolite and inhibits thymidilate synthetase Given by I.V infusion,orally Half life is 3-5 hours Thrombocytopenia and alopecia Lipophilic,broad spectrum fungicidal compound Inhibit squalene epoxidase Accumulation of squalene is toxic Orally given to treat worm infections Joint and muscle pains